Literature DB >> 21118188

Medical comorbidity in recurrent versus first-episode depressive patients.

M Gili1, M Garcia-Toro, M Vives, S Armengol, J Garcia-Campayo, J B Soriano, M Roca.   

Abstract

OBJECTIVE: This study compares the comorbidity of affective disorders and medical diseases in primary care patients with either a first or recurrent depressive episode.
METHOD: A cross-sectional epidemiological study in primary care centres in Spain was designed. A total of 10,257 primary care patients suffering a DSM-IV major depressive episode (MDD) were analysed. Depression was assessed using the Montgomery-Asberg Depression Rating Scale (MADRS), and World Health Organization (WHO) medical diagnoses were provided by the patient's general practitioner according to medical records revised on the basis of radiology or laboratory test data.
RESULTS: A total of 88.6% of recurrent patients and 71.1% of first-episode depressive patients reported a medical condition (aOR = 2.61, CI = 2.31-2.93). All medical conditions were more prevalent in the recurrent group than in first-episode group, and with the exception of myocardial infarction, psoriasis and migraine, all other crude ORs showed statistically significant differences between first- and recurrent episodes patients after adjusting for gender, age, education, socioeconomic status and body mass index (BMI).
CONCLUSION: Recurrent depression is associated with a decrement in health that is significantly greater than in first-episode depression. Special attention needs to be paid to the physical health in the middle- and long-term management of patients with affective disorders.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 21118188     DOI: 10.1111/j.1600-0447.2010.01646.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Trajectory classes of depressive symptoms in a community sample of older adults.

Authors:  M N Kuchibhatla; G G Fillenbaum; C F Hybels; D G Blazer
Journal:  Acta Psychiatr Scand       Date:  2011-11-25       Impact factor: 6.392

Review 2.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

3.  Stressful life events severity in patients with first and recurrent depressive episodes.

Authors:  M Roca; M Gili; J Garcia-Campayo; S Armengol; N Bauza; M García-Toro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-04-21       Impact factor: 4.328

4.  General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.

Authors:  D E Kemp; L G Sylvia; J R Calabrese; A A Nierenberg; M E Thase; N A Reilly-Harrington; M J Ostacher; A C Leon; T A Ketter; E S Friedman; C L Bowden; D J Rabideau; M Pencina; D V Iosifescu
Journal:  Acta Psychiatr Scand       Date:  2013-03-07       Impact factor: 6.392

5.  Efficacy of low-intensity psychological intervention applied by ICTs for the treatment of depression in primary care: a controlled trial.

Authors:  Adoración Castro; Azucena García-Palacios; Javier García-Campayo; Fermín Mayoral; Cristina Botella; José María García-Herrera; Mari-Cruz Pérez-Yus; Margalida Vives; Rosa M Baños; Miquel Roca; Margalida Gili
Journal:  BMC Psychiatry       Date:  2015-05-07       Impact factor: 3.630

Review 6.  Cumulative life damage in dermatology.

Authors:  Kristina Ibler; Gregor B E Jemec
Journal:  Dermatol Reports       Date:  2011-04-12

7.  Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).

Authors:  Antoine Yrondi; Djamila Bennabi; Emmanuel Haffen; Marion Garnier; Frank Bellivier; Thierry Bourgerol; Vincent Camus; Thierry D'Amato; Olivier Doumy; Frédéric Haesebaert; Jérôme Holtzmann; Christophe Lançon; Philippe Vignaud; Fanny Moliere; Isabel Nieto; Raphaëlle Marie Richieri; Philippe Domenech; Corentin Rabu; Luc Mallet; Liova Yon; Laurent Schmitt; Florian Stephan; Guillaume Vaiva; Michel Walter; Pierre-Michel Llorca; Philippe Courtet; Marion Leboyer; Wissam El-Hage; Bruno Aouizerate
Journal:  Front Psychiatry       Date:  2017-11-24       Impact factor: 4.157

8.  Efficacy of a blended low-intensity internet-delivered psychological programme in patients with multimorbidity in primary care: study protocol for a randomized controlled trial.

Authors:  Alicia Monreal-Bartolomé; Alberto Barceló-Soler; Adoración Castro; Mª Ángeles Pérez-Ara; Margalida Gili; Fermín Mayoral; Maria Magdalena Hurtado; Esperanza Varela Moreno; Cristina Botella; Azucena García-Palacios; Rosa M Baños; Yolanda López-Del-Hoyo; Javier García-Campayo
Journal:  BMC Psychiatry       Date:  2019-02-11       Impact factor: 3.630

9.  Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders.

Authors:  Marloes M J G Gerrits; Patricia van Oppen; Stephanie S Leone; Harm W J van Marwijk; Henriëtte E van der Horst; Brenda W Penninx
Journal:  BMC Psychiatry       Date:  2014-06-25       Impact factor: 3.630

Review 10.  Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance.

Authors:  Charles L Raison; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.